Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is lower by -22.98% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BIO stock a score of 30 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 15. BIO's rank also includes a long-term technical score of 16.
BIO has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on BIO!
Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is up 0.42% while the S&P 500 has risen 0.06% as of 1:00 PM on Friday, Nov 24. BIO has risen $1.31 from the previous closing price of $309.88 on volume of 65,002 shares. Over the past year the S&P 500 has risen 13.24% while BIO is lower by -22.98%. BIO lost -$5.56 per share in the over the last 12 months.
Click Here to get the full Stock Report for Bio-Rad Laboratories, Inc. Class A Common Stock stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
